5 Steps to Better Follow-Up Appointments
Libre 2 Continuous Glucose Monitor
Use this guide to support:
- Data interpretation
- Managing highs and lows
- Creating a joint action plan through collaborative decision-making
The FreeStyle Libre 2 app and FreeStyle Libre 3 app are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app or the FreeStyle Libre 3 app may require registration with LibreView.
Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. Medicare coverage is available for FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third-party payor criteria apply.
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
See Important Safety Information on last page.
Learn from data on the reader or app*
There are valuable reports within the reader and app* including:
- Ambulatory Glucose Profile (AGP)
- Glucose Pattern Insights (GPI)
- Time in Target
- Glucose Management Indicator (GMI)†
The Time in Target report can help you:
- Understand how long you spend in each glucose range at a glance
- See how food, medication, and activities cause your blood glucose levels to rise and fall
LibreView ‡ makes it easy to share § a full glycemic picture for more informed treatment decisions.
Getting started is easy:
- For Healthcare Professional: Add the patient’s email to the office’s LibreView patient list
OR - For Patient: Connect the Practice ID in the Linked Practices on the patient’s LibreView account
Add Practice ID here
Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. Medicare coverage is available for FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third-party payor criteria apply.
*The FreeStyle Libre 2 app and FreeStyle Libre 3 app are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app or the FreeStyle Libre 3 app may require registration with LibreView.†
The glucose management indicator report is only available on the FreeStyle Libre system apps. The FreeStyle Libre 2 and FreeStyle Libre 3 apps and the FreeStyle Libre 2 and FreeStyle Libre 3 readers have similar but not identical features. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.‡
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.§
The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
1. Vigersky, R. Diabetes Technology and Therapeutics (2019): https://doi.org/10.1089/dia.2018.0310.
See Important Safety Information on last page.
Identify glucose trends and patterns with reports
The LibreView* GPI Report can help you identify what may be causing the highs and lows in your glucose levels by trending your data over a 14-day window.
Factors to consider:
 |
Medications: • Avoid skipping, delaying, or missing doses |
 |
Exercise: • Engage in both anaerobic and aerobic activities, record the timing and duration of workouts, and notice any specific patterns |
 |
Sleep quality: • Observe sleep schedule and patterns and note if experiencing any changes in glucose levels |
 |
Meals: • Note when meals are typically eaten, the size of meals, alcohol consumption, and skipped meals |
 |
Shift work: • Watch when you usually sleep, and if sleep schedules change based on work shifts |
 |
Additional areas needing help: • Identify the areas with the most variability that could be crucial for improvement |
*The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
See Important Safety Information on last page.
Harness these insights for collaborative decision-making
Try an EASY framework to help control your glucose levels using actionable insights. You can customize each of these for your visit.
Create an EASY framework
- Engage with the data
- Adjust plan to improve patterns and time in range
- Set achievable goals and celebrate milestones
- You can be at the center of personalized healthcare
Stay on track
Monitor your time in range and remember to complete A1c testing at least semiannually, or quarterly if not meeting glycemic targets1.
LibreLinkUp
Share data with your caregivers through the LibreLinkUp*† app.
It can be invaluable in helping to achieve goals.
Take notes in the app‡ , and schedule your next appointment.
Keep the momentum going to ensure you stay on track.
We’re in this together to make diabetes management better for you.
Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. Medicare coverage is available for FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third-party payor criteria apply.
*The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of the LibreLinkUp app requires registration with LibreView. LibreLinkUp is not intended to be used for dosing decisions. The user should follow instructions on the continuous glucose monitoring system. LibreLinkUp is not intended to replace self-monitoring practices as advised by a physician.†
The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.‡
The FreeStyle Libre 2 app and FreeStyle Libre 3 app are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app or the FreeStyle Libre 3 app may require registration with LibreView.
1. American Diabetes Association. “Glycemic Goals and Hypoglycemia: Standards of Medical Care in Diabetes–2024.” Diabetes Care 47(suppl 1)(December 2024): S111-S125. https://doi.org/10.2337/dc24-S006.
IMPORTANT SAFETY INFORMATION
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or
https://www.freestyle.abbott/us-en/safety-information.html for safety info.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott.
© 2024 Abbott. ADC-85858 v1.0 11/23
Documents / Resources
 |
Abbott Libre 2 Continuous Glucose Monitor [pdf] Owner's Manual Libre 2, Libre 3, Libre 2 Continuous Glucose Monitor, Libre 2, Continuous Glucose Monitor, Glucose Monitor, Monitor |
